Natural Product: NPC293917

Natural Product IDNPC293917
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Bq-123
IUPAC Name 2-[(3S,6R,9S,12R,15S)-6-(1H-indol-3-ylmethyl)-9-(2-methylpropyl)-2,5,8,11,14-pentaoxo-12-propan-2-yl-1,4,7,10,13-pentazabicyclo[13.3.0]octadecan-3-yl]acetic acid
Synonyms BQ-123
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL1269102
PubChem CID 52943236
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0000013] Amino acids, peptides, and analogues
          • [CHEMONTID:0000348] Peptides
            • [CHEMONTID:0004831] Oligopeptides

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey VYCMAAOURFJIHD-AOYLRGCGSA-N
Standard InCHI InChI=1S/C31H42N6O7/c1-16(2)12-21-27(40)33-22(13-18-15-32-20-9-6-5-8-19(18)20)28(41)35-23(14-25(38)39)31(44)37-11-7-10-24(37)29(42)36-26(17(3)4)30(43)34-21/h5-6,8-9,15-17,21-24,26,32H,7,10-14H2,1-4H3,(H,33,40)(H,34,43)(H,35,41)(H,36,42)(H,38,39)/t21-,22+,23-,24-,26+/m0/s1
SMILES CC(C[C@@H]1N=C(O)[C@H](N=C(O)[C@@H]2CCCN2C(=O)[C@@H](N=C([C@H](N=C1O)Cc1c[nH]c2c1cccc2)O)CC(=O)O)C(C)C)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   610.31 Volume:   611.654
?
Van der Waals volume.
Dense:   0.998 LogP:   1.115
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.402
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -2.245
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   7.0 Rigid Bonds:   31.0
TPSA:   203.76
?
Topological Polar Surface Area.
H-Bond Acceptor:   13.0
H-Bond Donor:   6.0 Rings:   4.0
Heavy Atoms:   13.0

MedChem Properties

QED Drug-Likeness Score:   0.269 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   5.437 Fsp3:   0.548
MCE-18:   96.667
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.445 Fluc inhibitor:   0.026
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.061
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.798
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.001 Promiscuous compounds:   0.209

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.651 MDCK Permeability:   -5.102
Pgp-inhibitor:   0.889 Pgp-substrate:   0.979
PAMPA:   0.663
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.836
20% Bioavailability (F20%):   0.998 30% Bioavailability (F30%):   1.0
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.866
Plasma Protein Binding (PPB):   55.347% Volume Distribution (VD):   -0.295
Fu: 46.455%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   0.989 BCRP inhibitor:   0.077
BSEP inhibitor:   0.982

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.162 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.984 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.981 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.0
HLM stability:   0.019
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  1.371 Half-life (T1/2):  1.887

ADMET: Toxicity

hERG Blockers:  0.0 hERG Blockers (10um):  0.0
Human Hepatotoxicity (H-HT):  1.0 Drug-induced Liver Injury (DILI):  1.0
AMES Toxicity:  0.014 Rat Oral Acute Toxicity:  0.883
Maximum Recommended Daily Dose:  0.88 Skin Sensitization:  1.0
Carcinogencity:  0.652 Eye Corrosion:  0.0
Eye Irritation:  0.015 Respiratory Toxicity:  0.863
Drug-induced Neurotoxicity:  0.076 Ototoxicity:  0.992
Hematotoxicity:  0.612 Drug-induced Nephrotoxicity:  1.0
Genotoxicity:  1.0 RPMI-8226 Immunitoxicity:  0.0
A549 Cytotoxicity:  0.0 Hek293 Cytotoxicity:  0.0
BCF:   0.217
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.193
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.767
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.881
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO22874 Bombyx mori Species Bombycidae Eukaryota n.a. n.a. n.a. PMID[18071251]
NPO22874 Bombyx mori Species Bombycidae Eukaryota n.a. faeces n.a. PMID[18323202]
NPO22874 Bombyx mori Species Bombycidae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO22874 Bombyx mori Species Bombycidae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO22874 Bombyx mori Species Bombycidae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO22874 Bombyx mori Species Bombycidae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO22874 Bombyx mori Species Bombycidae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT247 Individual protein Endothelin receptor ET-A Homo sapiens IC50 = 22 nM PMID[15055997]
NPT247 Individual protein Endothelin receptor ET-A Homo sapiens Ki = 18 nM DOI[10.1016/0960-894X(95)00019-P]
NPT247 Individual protein Endothelin receptor ET-A Homo sapiens Inhibition = 25 % PMID[15139753]
NPT247 Individual protein Endothelin receptor ET-A Homo sapiens IC50 = 24.8 nM PMID[20932745]
NPT304 Individual protein Canalicular multispecific organic anion transporter 1 Rattus norvegicus Ki = 84100 nM PMID[9918561]
NPT247 Individual protein Endothelin receptor ET-A Homo sapiens IC50 = 20.5 nM PMID[22862294]
NPT5167 Individual protein Endothelin receptor ET-A Sus scrofa IC50 = 22 nM DOI[10.1016/0960-894X(95)00237-N]
NPT5792 Individual protein Endothelin receptor ET-B Sus scrofa IC50 = 18000 nM DOI[10.1016/0960-894X(95)00237-N]
NPT5167 Individual protein Endothelin receptor ET-A Sus scrofa IC50 = 22000 nM PMID[1315867]
NPT5792 Individual protein Endothelin receptor ET-B Sus scrofa IC50 = 23000 nM PMID[1315867]
NPT3952 Individual protein Endothelin receptor ET-B Homo sapiens IC50 > 1000 nM PMID[22862294]
NPT3951 Individual protein Endothelin receptor ET-A Rattus norvegicus IC50 = 14 nM PMID[9667964]
NPT5168 Individual protein Endothelin receptor ET-B Rattus norvegicus IC50 > 30000 nM PMID[9667964]
NPT5168 Individual protein Endothelin receptor ET-B Rattus norvegicus Ki = 7000 nM DOI[10.1016/0960-894X(95)00019-P]
NPT3951 Individual protein Endothelin receptor ET-A Rattus norvegicus Ki = 40 nM PMID[9857090]
NPT5168 Individual protein Endothelin receptor ET-B Rattus norvegicus Ki = 32000 nM PMID[9857090]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified n.a. Inhibition ~ 60 % PMID[14980650]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC293917 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.6837 Remote Similarity NPC31385
0.6596 Remote Similarity NPC489625
0.6569 Remote Similarity NPC479075
0.6545 Remote Similarity NPC483985
0.6429 Remote Similarity NPC107077
0.6421 Remote Similarity NPC213629
0.6381 Remote Similarity NPC479073
0.6373 Remote Similarity NPC110602
0.6373 Remote Similarity NPC479071
0.6321 Remote Similarity NPC479076
0.625 Remote Similarity NPC49954
0.6238 Remote Similarity NPC223791
0.6228 Remote Similarity NPC489555
0.616 Remote Similarity NPC485785
0.6132 Remote Similarity NPC479065
0.6095 Remote Similarity NPC155143
0.6 Remote Similarity NPC17059
0.5963 Remote Similarity NPC479066
0.5941 Remote Similarity NPC483341
0.5909 Remote Similarity NPC75726
0.5794 Remote Similarity NPC162860
0.5726 Remote Similarity NPC325976
0.5726 Remote Similarity NPC326363
0.5607 Remote Similarity NPC54420
0.5546 Remote Similarity NPC479574
0.5489 Remote Similarity NPC485786
0.5478 Remote Similarity NPC100321
0.5474 Remote Similarity NPC314603
0.5464 Remote Similarity NPC487314
0.5315 Remote Similarity NPC482001
0.525 Remote Similarity NPC69843
0.5238 Remote Similarity NPC171317
0.5194 Remote Similarity NPC486283
0.5188 Remote Similarity NPC485787
0.5149 Remote Similarity NPC75634
0.5051 Remote Similarity NPC34779

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC293917 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
1.0 High Similarity NPD7621 Clinical (unspecified phase)
0.74 Intermediate Similarity NPD7711 Discontinued
0.5143 Remote Similarity NPD7470 Discontinued
0.5041 Remote Similarity NPD8493 Clinical (unspecified phase)

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data